Has BioDelivery Sciences International (BDSI) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 03/18/22
Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to DeclineZacks Investment Research • 03/02/22
BioDelivery Sciences International (BDSI) Just Flashed Golden Cross Signal: Do You Buy?Zacks Investment Research • 02/24/22
BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of MigraineGlobeNewsWire • 02/24/22
BIODELIVERY SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioDelivery Sciences International, Inc. - BDSIPRNewsWire • 02/17/22
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioDelivery Sciences International, Inc. BuyoutNewsfile Corp • 02/15/22
SHAREHOLDER ALERT: WeissLaw LLP Investigates BioDelivery Sciences International, Inc.PRNewsWire • 02/15/22
BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing TodayInvestorPlace • 02/14/22
BDSI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of BioDelivery Sciences International, Inc. Is Fair to ShareholdersBusiness Wire • 02/14/22
Shareholder Alert: Ademi LLP investigates whether BioDelivery Sciences International, Inc. has obtained a Fair Price in its transaction with Collegium.PRNewsWire • 02/14/22
BioDelivery's stock rockets toward a 2-year high after buyout deal with Collegium at a 54% premiumMarket Watch • 02/14/22
Why the Earnings Surprise Streak Could Continue for BioDelivery (BDSI)Zacks Investment Research • 02/07/22